01 8BRISTOL
01 49585883
02 4RE50050
01 4Y
02 4Blank
01 4Y
02 4Blank
01 42034-06-19
02 42036-04-28
Patent Expiration Date : 2034-06-19
US Patent Number : 9585883
Drug Substance Claim :
Drug Product Claim :
Application Number : 214998
Patent Use Code : U-3373
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-06-19
Patent Expiration Date : 2034-06-19
US Patent Number : 9585883
Drug Substance Claim :
Drug Product Claim :
Application Number : 214998
Patent Use Code : U-3373
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-06-19
Patent Expiration Date : 2034-06-19
US Patent Number : 9585883
Drug Substance Claim :
Drug Product Claim :
Application Number : 214998
Patent Use Code : U-3373
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-06-19
Patent Expiration Date : 2034-06-19
US Patent Number : 9585883
Drug Substance Claim :
Drug Product Claim :
Application Number : 214998
Patent Use Code : U-3373
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-06-19
Patent Expiration Date : 2036-04-28
US Patent Number : RE50050
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 214998
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-04-28
Patent Expiration Date : 2036-04-28
US Patent Number : RE50050
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 214998
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-04-28
Patent Expiration Date : 2036-04-28
US Patent Number : RE50050
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 214998
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-04-28
Patent Expiration Date : 2036-04-28
US Patent Number : RE50050
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 214998
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-04-28
